Skip to main content

Advertisement

SpringerLink
Log in

Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Zinc deficiency has been observed in cirrhosis, but management guidelines do not address screening for zinc deficiency. We aim to determine the prevalence of zinc deficiency in different stages of cirrhosis and to correlate zinc levels with complications of cirrhosis and clinical outcomes. Patients who had a diagnosis of cirrhosis and had serum zinc levels drawn from 2007 to 2011 were identified. Demographics, laboratory data, presence of ascites, encephalopathy, and infection were obtained; Child–Pugh and MELD scores were calculated. Stata software was used for data analysis. A total of 163 patients were included in the study.

Results

The median serum zinc level was 0.47 mcg/ml (IQR 0.37–0.63); 83 % of patients were zinc deficient. Zinc deficiency was more prevalent in patients with Child–Pugh score B or C, and with MELD scores ≥15. Zinc levels were lower in alcoholic, hepatitis C, and cholestatic diseases than in other etiologies of liver disease. Zinc levels correlated with INR (r = −0.56, p < 0.001), bilirubin (r = −0.51, p < 0.001), and albumin (r = 0.68, p < 0.001), and were lower in patients with ascites (0.40 vs. 0.57 mcg/ml, p < 0.001), encephalopathy (0.40 vs. 0.53 mcg/ml, p < 0.001), diuretic use (0.45 vs. 0.535 mcg/ml, p = 0.005), and infection (0.32 vs. 0.51 mcg/ml, p < 0.001). Ascites (p = 0.044) and infection (p = 0.009) were independently associated with zinc levels. Zinc-deficient patients had lower transplant-free survival rates than non-deficient patients.

Conclusion

Zinc deficiency is highly prevalent in cirrhotic patients with Child–Pugh score B or C, and with MELD score ≥15. Zinc deficiency also correlates with disease severity, infection, and a worse transplant-free survival. Screening for zinc deficiency should be considered in this subset of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

MELD:

Model for end-stage liver disease

INR:

International normalized ratio

IQR:

Interquartile range

AST:

Aspartate aminotransferase

ALT:

Alanine aminotransferase

References

  1. Bartholomay AF, Robin ED, Vallee RL, Wacker WE. Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laennec’s cirrhosis and their validation by sequential analysis. N Engl J Med. 1956;255:403–408.

    Article  CAS  PubMed  Google Scholar 

  2. Fredricks RE, Tanaka KR, Valentine WN. Zinc in human blood cells: normal values and abnormalities associated with liver disease. J Clin Investig. 1960;39:1651–1656.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Gil EB, Ruiz MM, Cantero HJ, Diez RA, Rodrigo MM. Zinc and liver cirrhosis. Acta Gastroenterol Belg. 1990;53:292.

    Google Scholar 

  4. Keeling PW, Jones RB, Hilton PJ, Thompson RP. Reduced leucocyte zinc in liver disease. Gut. 1980;21:561–564.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci. 2007;52:1595–1612.

    Article  CAS  PubMed  Google Scholar 

  6. Rocchi E, Borella P, Borghi A, et al. Zinc and magnesium in liver cirrhosis. Eur J Clin Invest. 1994;24:149–155.

    Article  CAS  PubMed  Google Scholar 

  7. Poo JL, Rosas-Romero R, Rodriguez F, et al. Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig Dis. 1995;13:136–142.

    Article  CAS  PubMed  Google Scholar 

  8. Umusig-Quitain P, Gregorio GV. High incidence of zinc deficiency among Filipino children with compensated and decompensated liver disease. J Gastroenterol Hepatol. 2010;25:387–390.

    Article  CAS  PubMed  Google Scholar 

  9. Pescovitz MD, Mehta PL, Jindal RM, Milgrom ML, Leapman SB, Filo RS. Zinc deficiency and its repletion following liver transplantation in humans. Clin Transplant. 1996;10:256–260.

    CAS  PubMed  Google Scholar 

  10. Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci. 1988;33:1096–1102.

    Article  CAS  PubMed  Google Scholar 

  11. Valberg LS, Flanagan PR, Ghent CN, Chamberlain MJ. Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci. 1985;30:329–333.

    Article  CAS  PubMed  Google Scholar 

  12. Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP. Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci. 1981;61:441–444.

    Article  CAS  PubMed  Google Scholar 

  13. Scholmerich J, Becher MS, Kottgen E, et al. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis. Hepatogastroenterology. 1983;30:143–147.

    CAS  PubMed  Google Scholar 

  14. Ijuin H. Evaluation of pancreatic exocrine function and zinc absorption in alcoholism. Kurume Med J. 1998;45:1–5.

    Article  CAS  PubMed  Google Scholar 

  15. Giroux EL, Durieux M, Schechter PJ. A study of zinc distribution in human serum. Bioinorg Chem. 1976;5:211–218.

    Article  CAS  PubMed  Google Scholar 

  16. Schechter PJ, Giroux EL, Schlienger JL, Hoenig V, Sjoerdsma A. Distribution of serum zinc between albumin and alpha2-macroglobulin in patients with decompensated hepatic cirrhosis. Eur J Clin Invest. 1976;6:147–150.

    Article  CAS  PubMed  Google Scholar 

  17. Lindeman RD, Baxter DJ, Yunice AA, Kraikitpanitch S. Serum concentrations and urinary excretions of zinc in cirrhosis, nephrotic syndrome and renal insufficiency. Am J Med Sci. 1978;275:17–31.

    Article  CAS  PubMed  Google Scholar 

  18. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology. 1996;23:1084–1092.

    Article  CAS  PubMed  Google Scholar 

  19. Riggio O, Ariosto F, Merli M, et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci. 1991;36:1204–1208.

    Article  CAS  PubMed  Google Scholar 

  20. Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet. 1984;2:493–495.

    Article  CAS  PubMed  Google Scholar 

  21. Chavez-Tapia NC, Cesar-Arce A, Barrientos-Gutierrez T, Villegas-Lopez FA, Mendez-Sanchez N, Uribe M. A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy. Nutr J. 2013;12:74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080–1090.

    Article  CAS  PubMed  Google Scholar 

  23. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68:447S–463S.

    CAS  PubMed  Google Scholar 

  24. Wong CP, Ho E. Zinc and its role in age-related inflammation and immune dysfunction. Mol Nutr Food Res. 2012;56:77–87.

    Article  CAS  PubMed  Google Scholar 

  25. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004;24:277–298.

    Article  CAS  PubMed  Google Scholar 

  26. Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003;133:1452S–1456S.

    CAS  PubMed  Google Scholar 

  27. Yoffe B, Pollack S, Ben-Porath E, Zinder O, Barzilai D, Gershon H. Natural killer cell activity in post-necrotic cirrhotic patients as related to hepatitis-B virus infection and plasma zinc levels. Immunol Lett. 1986;14:15–19.

    Article  CAS  PubMed  Google Scholar 

  28. Allen JI, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med. 1983;102:577–589.

    CAS  PubMed  Google Scholar 

  29. Kabu K, Yamasaki S, Kamimura D, et al. Zinc is required for Fc epsilon RI-mediated mast cell activation. J Immunol. 2006;177:1296–1305.

    Article  CAS  PubMed  Google Scholar 

  30. Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology. 1989;68:114–119.

    PubMed Central  CAS  PubMed  Google Scholar 

  31. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol. 1997;272:E1002–E1007.

    CAS  PubMed  Google Scholar 

  32. Dowd PS, Kelleher J, Guillou PJ. T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br J Nutr. 1986;55:59–69.

    Article  CAS  PubMed  Google Scholar 

  33. DePasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr. 1984;114:1762–1769.

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. 5841 S Maryland Ave MC 7120, Chicago, IL, 60637, USA

    Shreya Sengupta, Kristen Wroblewski, Andrew Aronsohn, Nancy Reau, K. Gautham Reddy, Donald Jensen & Helen Te

Authors
  1. Shreya Sengupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristen Wroblewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew Aronsohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nancy Reau
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Gautham Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Donald Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Helen Te
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shreya Sengupta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sengupta, S., Wroblewski, K., Aronsohn, A. et al. Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?. Dig Dis Sci 60, 3130–3135 (2015). https://doi.org/10.1007/s10620-015-3613-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3613-0

Keywords

Search

Navigation